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48 The Journal of Thoracic and Cardiobjective: Aprotinin is a serine protease inhibitor used during cardiac surgery to
educe blood loss and preserve platelet function. It has also been shown to reduce
eukocyte activation during and after cardiopulmonary bypass. The goal of the study
as to test the hypothesis that aprotinin could reduce cerebral injury after low-flow
ardiopulmonary bypass and deep hypothermic circulatory arrest.
ethods: Sixteen piglets (mean weight, 13.6  1.3 kg) were randomly assigned to
eceive aprotinin or placebo (8 animals per group) before a 120-minute period of
eep hypothermic circulatory arrest (15°C) or 25 mL · kg1 · min1 low-flow
ardiopulmonary bypass (25°C or 34°C). Piglets had a cranial window placed
ver the parietal cerebral cortex for direct examination of the microcirculation
y means of intravital microscopy. Rhodamine-stained leukocytes were ob-
erved in postcapillary venules, with analysis for adhesion and rolling. Plasma
as labeled with fluorescein isothiocyanate– dextran for assessment of func-
ional capillary density. Neurologic and histologic scores were used as the
rimary outcome measures.
esults: During rewarming, the mean number of both rolling and adherent leuko-
ytes was significantly lower after aprotinin administration (P  .05). At 5 and 15
inutes of rewarming, functional capillary density recovered faster with aprotinin
reatment (P  .05). Functional outcome (neurologic deficit score) on postoperative
ay 1 was significantly improved in aprotinin-treated piglets (P  .05).
onclusions: Aprotinin reduces inflammation and improves neurologic outcome
fter a prolonged period of deep hypothermic circulatory arrest or low-flow cardio-
ulmonary bypass.
protinin is a broad-spectrum serine protease inhibitor that has been in
clinical use since the late 1980s to reduce blood loss and preserve platelet
function during cardiac surgery.1,2 Aprotinin has broad hemostatic prope
ies that are mediated by blocking pathways of complement activation and fibrino-
ysis through inhibition of multiple proteases, including trypsin, plasmin, and
allikrein.3 Aprotinin has been shown to mitigate kallikrein-induced increase
erum bradykinin and associated brain edema in animal models.4 Within the
irculation, aprotinin has been shown to significantly reduce neutrophil activation
uring and after cardiopulmonary bypass (CPB).5,6 Aprotinin directly reduces th
nflammatory response at the leukocyte action level through inhibition of the
pregulation of the proinflammatory CD11b integrin.5 This integrin plays a key ro
n the attachment of the neutrophil to the endothelial surface during an inflammatory
esponse and also facilitates subsequent transmigration of the neutrophil into the
xtravascular space. Aprotinin has also been demonstrated to block leukocyte
xtravasation in a rat model by using intravital microcopy.7 This can be due to t
argeting of soluble proteases, either directly, as in the case of elastase secreted by
vascular Surgery ● October 2006
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Phe migrating cell,8 or indirectly, as in the case of ma
etalloproteinase activation by plasmin.9,10
Aprotinin has been shown to rescue dying neurons
rom cell death and to even restore their resting potential
n the weaver mouse.11 The cell death in this mouse 
een attributed to a mutation in the GIRK2 potassium
hannel, which renders the channel overly excitable. Be-
ause it has been shown that serine protease inhibitors
ave a 3-dimensional structure similar to that of potassium-
hannel blockers,12 it could be hypothesized that the neu-
rotection by aprotinin might be attributed to this blockage
f the malfunctioning potassium channel.13
Protease inhibitors other than aprotinin have been demon-
trated recently to reduce N-methyl-D-aspartate–mediated ex-
itotoxic cerebral injury. We conducted this study to inves-
igate whether aprotinin could improve cerebral outcome
fter a prolonged period of deep hypothermic circulatory
rrest (DHCA) and low-flow CPB. Intravital microscopy
as used to investigate cerebral microcirculation, including
eukocyte activation and functional capillary density (FCD).
pplying this technique in a survival experimental model
rovides the opportunity to study microvascular distur-
ances and compare them with functional and histologic
utcomes.
aterials and Methods
nimals
ixteen juvenile (6-7 weeks) Yorkshire piglets with a mean body
eight 13.6  1.3 kg were randomly assigned to receive either
protinin or saline (8 animals per group) before a 120-minute
eriod of DHCA at 15°C or low-flow perfusion (25 mL · kg1 ·
in1) at 25°C or 34°C.
All animals received humane care in accordance with the
Principles of Laboratory Animal Care” formulated by the Na-
ional Society for Medical Research and the “Guide for the Care
nd use of Laboratory Animals” prepared by the Institute of
aboratory Animal Resources, National Research Council, and
ublished by the National Academy Press, revised in 1996.
The study was approved by the Animal Care and Use Com-
ittee of the Children’s Hospital Boston.
rug Administration
iglets in the aprotinin group received the drug (Trasylol; Bayer,
est Haven, Conn) according to the following prescription: load-
ng dose of aprotinin of 30,000 KIU/kg (kallikrein inhibitor units)
Abbreviations and Acronyms
ANOVA analysis of variance
CPB  cardiopulmonary bypass
DHCA  deep hypothermic circulatory arrest
FCD  functional capillary density
NDS  neurologic deficit scoredministered intravenously, pump priming of 30,000 KIU/kg, and t
The Journal of Thoracicaintenance intravenous infusion of 10,000 KIU · kg1 · h1.
protinin was discontinued within 2 hours after weaning from
PB. Control animals received the same volume of saline infusion.
he aprotinin dose was the same as that used clinically. Random-
zation envelopes were opened, drug or saline syringes were pre-
ared by a laboratory technician, and the codes were broken after
he entire series of experiments was accomplished. Therefore all
bservers in every data recording point were unaware of whether
he animal received aprotinin or was a control animal.
urgical Preparation
fter premedication with an intramuscular injection of ketamine
20 mg/kg) and xylazine (4 mg/kg), the piglets were intubated and
entilated with 21% oxygen at a respiratory rate of between 18 to
0 breaths/min to achieve an arterial PCO2 of 35 to 40 mm Hg.
fter induction with fentanyl (25 g/kg administered intrave-
ously), anesthesia was maintained with continuous infusion of
entanyl (25 g · kg1 · h1), midazolam (0.2 mg · kg1 · h1),
nd pancuronium (0.2 mg · kg1 · h1). Temperature probes were
laced into the esophagus and rectum. A cannula (19G Intracath;
ecton Dickinson, Sandy, Utah) was inserted in the left superficial
emoral artery and advanced into the abdominal aorta for contin-
ous blood pressure monitoring. For anesthesia infusion, a cannula
19G Intracath, Becton Dickinson) was introduced through the
ight femoral vein into the inferior vena cava. After systemic
eparinization (300 IU/kg administered intravenously) and a right
nterolateral thoracotomy in the third intercostal space, an 8F
rterial cannula (Bio-Medicus; Medtronic Inc, Eden Prairie, Minn)
as inserted through the right femoral artery into the abdominal
orta, and a 28F cannula (Harvey; Bard, Tewksbury, Mass) was
nserted into the right atrium for CPB. The piglets were positioned
rone in a stereotactic frame, and a cranial window (15  15 mm)
as created over the parietal cerebral cortex with an electric drill.
fter incision of the dura, the surface (pial) vessels were visual-
zed. The cranial window was closed with a glass cover slip.
xperimental Protocol
ixteen piglets were randomized according to the experimental
rotocol. Six piglets were subjected to the 15°C DHCA, 6 piglets
3 per group) to the 25°C low-flow CPB with a flow rate of 25 mL ·
g1 · min1, and 4 piglets (2 per group) to the 34°C low-flow
PB with a flow rate of 25 mL · kg1 · min1. The duration of
HCA and the low-flow period was 120 minutes. In every group
alf of the animals were randomized to receive aprotinin or saline
ccording to the protocol.
PB Technique
he CPB circuit consisted of a roller pump (Cardiovascular In-
trument Corp, Wakefield, Mass), membrane oxygenator (Mini-
ax; Medtronic Inc, Anaheim, Calif ), and sterile tubing with a
0-m arterial filter. Fresh whole blood from a donor pig was
ransfused into the prime to adjust the hematocrit level to 30%.
ethylprednisolone (30 mg/kg), furosemide (0.25 mg/kg), sodium
icarbonate 7.4% (10 mL), and cephazolin sodium (25 mg/kg)
ere added to the prime before the start of CPB. The pH-stat
trategy was used (sweep gas 95% O2/5% CO2). The gas flow was
djusted to achieve an arterial PCO of 40 to 45 mm Hg (corrected2
o nasopharyngeal temperature). After baseline recordings, CPB
and Cardiovascular Surgery ● Volume 132, Number 4 949
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CSPith a flow rate of 100 mL · kg1 · min1 was started, and the
nimals were perfused for 10 minutes at normothermia (esopha-
eal temperature, 37°C). Ventilation was stopped after the estab-
ishment of CPB. The piglets underwent 40 minutes of cooling on
PB to an esophageal temperature of 15°C, 25°C, or 34°C. After
ooling, DHCA or low-flow perfusion at a flow rate of 25 mL ·
g1 · min1 was initiated for 120 minutes. Before rewarming,
odium bicarbonate 7.4% (10 mL), methylprednisolone (30 mg/
g), furosemide (0.25 mg/kg), and mannitol (0.5 g/kg) were ad-
inistered into the pump. During 40 minutes of rewarming, ani-
als were warmed to 37°C with a flow rate of 100 mL · kg1 ·
in1. The heart was defibrillated, if necessary, at an esophageal
emperature of 30°C. Ventilation (100% oxygen) was started 10
inutes before weaning from CPB. Protamine (5 mg/kg) was
dministered intravenously after the animal was hemodynamically
table. The wounds were closed in a sterile fashion.
Arterial pressure was monitored continuously throughout each
xperiment and was recorded every 15 minutes. Hemoglobin
alue, hematocrit value, glucose value, lactate value, PO2, PCO2,
nd pH were measured every 15 minutes on CPB, at 30 minutes
fter CPB, and once an hour until extubation with a blood gas
nalyzer (Stat Profile 9; Nova, Waltham, Mass).
Animals remained sedated and paralyzed with a continuous
nfusion of fentanyl (50 g · kg1 · h1), midazolam (0.2 mg ·
g1 · h1), and pancuronium (0.2 mg · kg1 · h1) and were
echanically ventilated (21% oxygen) and monitored continu-
usly for 12 hours after the operation. The chest tubes were
emoved, and the animals were extubated.
ntravital Fluorescence Microscopy
n epifluorescence microscope (Model MZ FLIII; Leica, Heer-
rugg, Switzerland) with a 100-W mercury gas discharge lamp
quipped with a rapid filter exchanger was placed over the cranial
indow. The microscope included 2 sets of filters: a blue filter set
450-490 nm excitation/515-nm emission wavelength) for visu-
lization of fluorescein fluorescence and a green filter set (536-556
m excitation/590-nm emission wavelength) for visualization of
hodamine-labeled leukocytes. The microscope images from the
harge-coupled device video camera (Dage-300-RC; Dage-MTI,
ichigan City, Ind) were time stamped with a time-code generator
VTG-33; For-A, Tokyo, Japan). The images were transferred to a
igh-resolution 12-inch monitor (Dage HR-1000, Dage-MTI) and
ideotaped. A Scion LG-3 frame grabber card (Scion Corp, Fred-
rick, Md) and computer-assisted image analysis system (NIH
mage; National Institutes of Health, Bethesda, Md) were used for
ubsequent offline analysis. The final magnification on the monitor
as 400.
For the assessment of leukocyte–endothelial cell interactions, the
irculating leukocytes were labeled with 2 mL of rhodamine-6G
.2% (Sigma Chemical, St Louis, Mo). The numbers of adherent
adherent leukocytes/100-m vessel length) and rolling (rollers/
00-m vessel length per minute) leukocytes in 20- to 30-m
iameter postcapillary venules were observed. A green filter set
as used to excite rhodamine fluorescence.
Plasma was labeled with 1 mL of fluorescein isothiocyanate–
extran 5% (150 kD, Sigma Chemical) before each subsequent
easurement to visualize microvascular FCD, defined as the totalength of erythrocyte-perfused capillaries per observation area, and c
50 The Journal of Thoracic and Cardiovascular Surgery ● Octohe diameter of arteries and venules. The fluorescein isothiocya-
ate fluorescence was excited with the blue filter set. The plasma
ecame highlighted, and the red blood cells appeared dark (nega-
ive contrast). The diameter of 60- to 100-m arterial and venous
erebrocortical microvessels was measured from video still images
y using an image analysis program. On average, 4 to 5 arterioles
nd 3 to 4 venules per observation area were measured.
Intravital fluorescence microscopy was performed at baseline;
t 10 minutes of normothermic CPB; at 20 minutes of cooling; at
he end of cooling; at every 15 minutes during the low-flow period;
t 5, 15, 30, and 40 minutes of rewarming; and at 30 and 60
inutes after weaning from CPB. The duration of brain tissue
pi-illumination was limited to less than 1 minute to avoid thermal
njury of tissue, and it was always shut off between video
ecordings.
ostoperative Evaluation
fter the operation, neurologic and behavioral evaluations were
erformed at 24-hour intervals by a senior veterinarian blinded to
he experimental protocol beginning on postoperative day 1. Neu-
ologic scoring was adapted from the neurologic deficit score
NDS: 500  brain death, 0  normal).14
istopathologic Analysis
n postoperative day 4, all surviving piglets were sedated by using
ntramuscular induction with ketamine (20 mg/kg) and xylazine
4 mg/kg) and anesthetized with intravenous fentanyl (50 g/kg).
fter a midline sternotomy, heparin (300 IU/kg) was administered,
nd a cannula was inserted into the left common carotid artery. The
ortic arch was clamped, and 1 L of Plasmalyte solution (Baxter,
eerfield, Ill) was infused through the left common carotid artery.
lood was suctioned from the superior vena cava until the perfus-
te was clear of blood. Then 3 L of 10% formalin solution was
erfused through the brain in the same manner to accomplish
erfusion fixation. The entire head of the piglet was immersed in
0% formalin for a week, and the brain was harvested and fixed
ith 10% formalin solution for the histologic assessment.15
The preparation of the cerebral specimens and the details of
sed analyses have been described previously.15,16 Specimens from
regions of the brain (neocortex, hippocampus, dentate gyrus, cau-
ate nucleus, thalamus, and cerebellum) were examined. Histologic
amage was scored by using the following criteria: 5, cavitated
esions with necrosis; 4, significant damage to neurons; 3, large
lusters of injured neurons; 2, small clusters of damaged neurons; 1,
solated neuronal damage; 0, normal. A single neuropathologist
H.G.W.L.) examined all specimens in a blinded fashion.
tatistical Analysis
ontinuous variables are expressed as means  standard devia-
ion. Kolmogorov-Smirnov test indicated that the variables fol-
owed a normal distribution. Repeated-measures analysis of vari-
nce (ANOVA) was used to evaluate changes over time and to
ompare rates of change between the aprotinin and control groups
ith respect to changes in FCD over time, as well as to evaluate
ny differences between the 2 groups regarding mean arterial
ressure, hematocrit value, arterial pH, and hemoglobin valu17
wo-way ANOVA was used to test for differences in leukocyte
ounts (adherent and rolling) during rewarming and neurologic
ber 2006
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Pecovery by evaluating F-tests’ main effects for temperature and
he use of aprotinin and the 2-way interaction. This multivariable
pproach allowed an interpretation of the effects of temperature
nd aprotinin treatment. Plots were constructed to show mean
alues of leukocytes and NDSs for animals in the no-aprotinin
control) group and the aprotinin (treatment) group for each
HCA or low-flow CPB condition. A significant downward slope
ndicated that aprotinin reduced the number of leukocytes during
ewarming or led to lower neurologic/histologic scores. A differ-
nce in intercepts between the 15°C and DHCA, 25°C and 25 mL ·
g1 · min1, and 34°C and 25 mL · kg1 · min1 groups
ndicated differences in outcomes (leukocyte counts or brain injury
cores) as a result of temperature conditions. The nonparametric
pearman rho () correlation coefficient was used to measure the
ssociation between intravital microscopy data and temperature
nd flow rate. Statistical analysis was performed with the SPSS
ackage (version 13.0; SPSS Inc, Chicago, Ill).
esults
here were no statistically significant differences at baseline
before CPB) between the experimental groups regarding
ematocrit values, blood gases, mean arterial pressure,
hole-body lactate values, or intravital microscopy data.
ean arterial pressure, hematocrit values, arterial pH, and
emoglobin values were analyzed by using 2-way repeated-
easures ANOVA. No significant differences were found be-
ween the aprotinin and control groups for any of these 4
ariables throughout the time period from baseline, low-flow
ypass, and rewarming to weaning from the pump. The F-test
or the aprotinin group versus the control group was not sig-
ificant for mean arterial pressure (F  0.22, P  .65), he-
atocrit values (F 0.71, P  .43), pH (F 1.94, P  .20),
r hemoglobin values (F  0.53, P  .49). In the baseline
ematocrit levels were 32%  2% in the aprotinin group and
2%  4% in the control group. Sixty and 180 minutes after
eaning from pump, hematocrit levels were 28%  4% and
7%  2% and 26%  3 and 25%  3%, respectively.
eukocyte–Endothelial Cell Interactions
t the end of the cooling period, more adherent leukocytes
ere found at 34°C compared with at 15°C (P  .04) in
ostcapillary venules. At that time point, temperature was
ositively correlated with the number of adherent leuko-
ytes (Spearman   0.50, P  .05).
A significant inverse correlation was found between the
se of aprotinin and the number of rolling and adherent
eukocytes during the rewarming period (Spearman  
0.49 to 0.60, P  .05). Aprotinin was a multivariable
redictor of a decreased number of rolling leukocytes dur-
ng the rewarming period (F  5.25, P  .04). At 15°C, the
ean number of rolling leukocytes with aprotinin was 0.8
.4, and without aprotinin, it was 1.5  0.7. At 25°C, the
orresponding numbers were 1.8  0.3 and 4.3  2, and at
4°C, they were 2.2  1.7 and 3.4  1.5, respectively
Figure 1, A). Lower temperature and aprotinin were mul- i
The Journal of Thoracicivariable predictors of the decreased number of adherent
eukocytes during the rewarming period (F  7.53, P 
008 and F  13.56, P  .003, respectively). The mean
umber of adherent leukocytes was 5.0 0.4 with aprotinin
nd 5.8  2.1 without aprotinin at 15°C. At 25°C, the
orresponding numbers were 3.2  0.5 and 4.6  0.3, and
t 34°C, they were 5.9  0.5 and 7.0  0.3, respectively.
here were no significant 2-way interactions between tem-
erature and aprotinin (Figure 1, B).
unctional Capillary Density
CD increased in all animals from baseline (100%) to normo-
hermic CPB (115%  5%), but there were no differences
etween the groups. At the end of cooling, FCD was signifi-
antly less in animals at 15°C (91% 1%) compared with that
een in the 34°C group (103%  11%, P  .05).
At the beginning of rewarming (5 and 15 minutes), FCD
ecovered significantly faster after aprotinin administration
elative to that seen in control animals (78.4%  14.4% vs
2.8% 20.7% [F 14.43, P .003] and 96.3% 12.9%
s 83.4%  21.7% [F  12.88, P  .03], respectively). At
hese time points, after 2 hours of DHCA at 15°C, aprotinin
reatment was associated with significantly improved FCD
ompared with that seen in control animals (P  .05).
orbidity and Mortality
ll animals were stable during the surgical procedures and
urvived to at least the first postoperative day. Fourteen of
he 16 animals survived the planned 4 days after the oper-
tion and were electively killed. One control animal sub-
ected to 15°C DHCA stayed comatose and died on post-
perative day 1 of severe brain damage, and another animal
n the 15°C DHCA with aprotinin group was killed after
epeated seizures on postoperative day 2.
eurologic and Behavioral Evaluations
he NDS category showed relatively rapid recovery in all
urviving animals. DHCA was predictive of delayed neuro-
ogic recovery (F  20.48, P  .001), whereas aprotinin was
redictive of faster recovery (F  4.71, P  .05; Figure 1, C).
istologic Assessment
istologic scores were quite low, except when DHCA was
sed. When a 25 mL · kg1 · min1 flow rate was used, no
ignificant differences in histologic scores were found be-
ween aprotinin-treated and control animals, although at
4°C, scores tended to be lower with aprotinin (F  2.79,
  .12; Table 1 and Figure 1, D).
iscussion
he results of this study indicate that aprotinin might im-
rove cerebral outcome after a prolonged period of DHCA
nd low-flow CPB. A better outcome was seen in terms of
nflammatory response, faster recovery of FCD, and NDSs.
and Cardiovascular Surgery ● Volume 132, Number 4 951
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CSPhe results confirm those of previous studies suggesting that
protinin has a neuroprotective effects.11
A principal finding of this study was that aprotinin mit-
gates leukocyte activation during CPB. White cell activa-
ion, adhesion to endothelium, and subsequent transendo-
helial migration have been shown to result from CPB as
 part of the systemic inflammatory response.18 Adhesion
olecules, including selectins, 2-integrins, and the immu-
oglobulin superfamily, play important roles during inflam-
ation.19 It has been shown that leukocyte expression
2-integrin increases significantly during CPB, but aprotinin
dministration prevents this.6 Our previous study showe
hat higher temperature was correlated with a greater num-
er of activated leukocytes during CPB.20 In the curren
tudy we were able to demonstrate that aprotinin adminis-
ration reduces the number of adherent leukocytes in post-
apillary venules during the rewarming period after mildly
ypothermic (34°C) bypass.
An interesting finding of our study was that after apro-
inin administration, FCD recovered more rapidly during
he early rewarming period after a prolonged period of
HCA. This finding contrasts with previous concerns that
protinin could result in clotting in small vessels when used
n the setting of DHCA. Nevertheless, our finding is sup-
orted by a previous study demonstrating that aprotinin
nhibits thrombin-induced platelet activation by preventing
roteolysis of the protease-activated receptor 1 receptor, and
hat suggests instead that aprotinin might have significant
ntithrombotic effects.21 At 5 minutes of rewarming af
hours of DHCA, we detected areas of the cerebral micro-
irculation with very slow or no-flow and low capillary
ensity, but there were fewer of these areas after aprotinin
igure 1. A, Use of aprotinin was predictive of a decreased
umber of rolling leukocytes during rewarming (F  5.25, P 
04), which was consistent for all 3 conditions. Data points
epresent actual mean values. No error bars are shown because
f small sample sizes, although there is a description in the text.
, Use of aprotinin was predictive of a decreased number of
dherent leukocytes during rewarming (F  13.56, P  .003),
hich is consistent for all 3 hypothermic circulatory arrest and
ow-flow bypass conditions. Data points represent actual mean
alues. No error bars are shown because of small sample sizes,
lthough there is a description in the text. C, Aprotinin was a
ultivariable predictor for faster neurologic recovery (F  4.71,
< .05), which is consistent for all 3 hypothermic circulatory
rrest and low-flow bypass conditions. Data points represent
ctual mean values. D, Histologic scores were low, except when
HCA was used. By using a flow rate of 25 mL · kg1 · min1, no
ignificant differences in histologic scores were found between
protinin-treated and control animals. However, at 34°C, scores
ended to be lower with aprotinin (F  2.79, P  .12). HCA,
ypothermic circulatory arrest.
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Pdministration. However, the low- and no-flow areas recov-
red rapidly, and after 30 minutes of rewarming, when the
emperature had reached normothermia, essentially all ob-
erved areas had returned to baseline FCD.
The survival rate in the current study was 88%, and both
remature deaths occurred after 2 hours of DHCA. This no
oubt reflects the severity of our DHCA protocol. In terms of
ehavioral assessment, however, a better outcome was seen
mong aprotinin-treated animals. Histologic scores were quite
ow, except when DHCA was used. After DHCA, aprotinin
as associated with reduced histologic damage, but because
f the limited number of animals, a statistically significant
ifference was not found. After low-flow CPB, no signifi-
ant differences in histologic scores were found between
protinin-treated and control animals, although at 34°C,
cores tended to be lower with aprotinin.
Our data suggest that aprotinin mitigates the inflammatory
esponse and improves neurologic outcome after a prolonged
eriod of DHCA and low-flow CPB. The distribution of serine
roteases throughout the vasculature and their central role in
he inflammatory response might explain how a serine protease
nhibitor, such as aprotinin, can result in such a profound
nti-inflammatory mechanism of action.
In light of our results and other published studies, it
eems evident that aprotinin can reduce the inflammatory
esponse. However, an interesting question to be explored is
hether aprotinin penetrates the blood-brain barrier and
ight protect neuronal cells directly during ischemic dam-
ge in vivo. Additional studies are needed to provide clar-
fication on this fundamental issue.
eferences
1. van Oeveren W, Jansen NJ, Bidstrup BP, et al. Effects of aprotinin on
hemostatic mechanisms during cardiopulmonary bypass. Ann Thorac
Surg. 1987;44:640-5.
2. Royston D, Bidstrup BP, Taylor KM, Sapsford RN. Effect of aprotinin
on need for blood transfusion after repeat open-heart surgery. Lancet.
1987;2:1289-91.
3. Landis RC, Asimakopoulos G, Poullis M, Haskard DO, Taylor KM.
The antithrombotic and antiinflammatory mechanisms of action of
ABLE 1. Regional histologic scores and neurologic deficit
ypass
emperature, flow
mL · kg1 · min1) N
Histol
Neocortex Hippocampus Dentate gyru
4°C, 25, control 2 0 (0-0) 0 (0-0) 0 (0-0)
4°C, 25, aprotinin 2 0 (0-0) 0 (0-0) 0 (0-0)
5°C, 25, control 3 0 (0-0) 0 (0-0) 0 (0-0)
5°C, 25, aprotinin 3 0 (0-0) 0 (0-2) 0 (0-0)
5°C, HCA, control 3 2 (0-3) 0 (0-0) 0 (0-0)
5°C, HCA, aprotinin 3 0 (0-0) 0 (0-0) 0 (0-2)
istologic data are presented as medians with interquartile ranges, and neuro
eurologic deficit score on postoperative day 1; HCA, hypothermic circulatoraprotinin. Ann Thorac Surg. 2001;72:2169-75.
The Journal of Thoracic4. Kamiya T, Katayama Y, Kashiwagi F, Terashi A. The role of bradykinin
in mediating ischemic brain edema in rats. Stroke. 1993;24:571-5.
5. Hill GE, Alonso A, Spurzem JR, Stammers AH, Robbins RA. Aprotinin
and methylprednisolone equally blunt cardiopulmonary bypass-induced
inflammation in humans. J Thorac Cardiovasc Surg. 1995;110:1658-62.
6. Asimakopoulos G, Kohn A, Stefanou DC, Haskard DO, Landis RC,
Taylor KM. Leukocyte integrin expression in patients undergoing
cardiopulmonary bypass. Ann Thorac Surg. 2000;69:1192-7.
7. Asimakopoulos G, Thompson R, Nourshargh S, et al. An anti-inflamma-
tory property of aprotinin detected at the level of leukocyte extravasation.
J Thorac Cardiovasc Surg. 2000;120:361-9.
8. Cepinskas G, Noseworthy R, Kvietys PR. Transendothelial neutrophil
migration. Role of neutrophil-derived proteases and relationship to
transendothelial protein movement. Circ Res. 1997;81:618-26.
9. Carmeliet P, Moons L, Lijnen R, et al. Urokinase-generated plasmin
activates matrix metalloproteinases during aneurysm formation. Nat
Genet. 1997;17:439-44.
0. Moons L, Shi C, Ploplis V, et al. Reduced transplant arteriosclerosis in
plasminogen-deficient mice. J Clin Invest. 1998;102:1788-97.
1. Murtomaki S, Trenkner E, Wright JM, Saksela O, Liesi P. Increased
proteolytic activity of the granule neurons may contribute to neuronal
death in the weaver mouse cerebellum. Dev Biol. 1995;168:635-48.
2. Lancelin JM, Foray MF, Poncin M, Hollecker M, Marion D. Protein-
ase inhibitor homologues as potassium channel blockers. Nat Struct
Biol. 1994;1:246-50.
3. Siao CJ, Tsirka SE. Extracellular proteases and neuronal cell death.
Cell Mol Biol. 2002;48:151-61.
4. Forbess JM, Ibla JC, Lidov HG, et al. University of Wisconsin cere-
broplegia in a piglet survival model of circulatory arrest. Ann Thorac
Surg. 1995;60(suppl):S494-500.
5. Miura T, Laussen P, Lidov HG, DuPlessis A, Shin’oka T, Jonas RA.
Intermittent whole-body perfusion with “somatoplegia” versus blood
perfusate to extend duration of circulatory arrest. Circulation. 1996;
94(suppl):II56-62.
6. Shin’oka T, Shum-Tim D, Jonas RA, et al. Higher hematocrit im-
proves cerebral outcome after deep hypothermic circulatory arrest.
J Thorac Cardiovasc Surg. 1996;112:1610-20.
7. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful
in circulation research. Circ Res. 1980;47:1-9.
8. Boyle EM Jr, Pohlman TH, Johnson MC, Verrier ED. Endothelial cell
injury in cardiovascular surgery: the systemic inflammatory response.
Ann Thorac Surg. 1997;63:277-84.
9. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules.
Blood. 1994;84:2068-101.
0. Anttila V, Hagino I, Zurakowski D, Lidov HG, Jonas RA. Higher bypass
temperature correlates with increased white cell activation in the cerebral
microcirculation. J Thorac Cardiovasc Surg. 2004;127:1781-8.
1. Poullis M, Manning R, Laffan M, Haskard DO, Taylor KM, Landis
RC. The antithrombotic effect of aprotinin: actions mediated via the
protease-activated receptor 1. J Thorac Cardiovasc Surg. 2000;120:
es by temperature and flow rate during DHCA or low-flow
scores Sum
NDS POD 1audate nucleus Thalamus Cerebellum Total score
0 (0-0) 0 (0-0) 3 (0-3) 3 (2-3) 80 14
0 (0-0) 0 (0-0) 2 (0-2) 2 (1-2) 20 0
0 (0-0) 0 (0-0) 2 (0-3) 2 (2-3) 60 30
0 (0-0) 0 (0-3) 2 (0-2) 2 (2-4) 37 21
2 (0-3) 0 (0-0) 3 (0-3) 6 (5-9) 157 84*
1 (0-2) 0 (0-0) 1 (0-2) 4 (3-5) 212 32*
deficit score data are presented as means standard deviation. NDS POD1,
st. *P  .05 compared with each of the other low-flow conditions.scor
ogic
s C
logic370-8.
and Cardiovascular Surgery ● Volume 132, Number 4 953
